These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorder. Woodward TC, Tafesse E, Quon P, Lazarus A. Pharmacoeconomics; 2010; 28(9):751-64. PubMed ID: 20623994 [Abstract] [Full Text] [Related]
4. Quetiapine: a pharmacoeconomic review of its use in bipolar disorder. Plosker GL. Pharmacoeconomics; 2012 Jul 01; 30(7):611-31. PubMed ID: 22559293 [Abstract] [Full Text] [Related]
5. Maintenance treatment with quetiapine when combined with either lithium or divalproex in bipolar I disorder: analysis of two large randomized, placebo-controlled trials. Suppes T, Vieta E, Gustafsson U, Ekholm B. Depress Anxiety; 2013 Nov 01; 30(11):1089-98. PubMed ID: 23761037 [Abstract] [Full Text] [Related]
16. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania. Nasrallah HA, Brecher M, Paulsson B. Bipolar Disord; 2006 Oct 01; 8(5 Pt 1):467-74. PubMed ID: 17042884 [Abstract] [Full Text] [Related]
19. Treatment of bipolar depression: making sensible decisions. Citrome L. CNS Spectr; 2014 Dec 01; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667 [Abstract] [Full Text] [Related]
20. The role of quetiapine in the treatment of bipolar disorder. Pini S, Abelli M, Cassano GB. Expert Opin Pharmacother; 2006 May 01; 7(7):929-40. PubMed ID: 16634715 [Abstract] [Full Text] [Related] Page: [Next] [New Search]